API | hexylresorcinol

hexylresorcinol Report issue

Small molecule Experimental

ChEMBL DrugBank Drug Central KEGG MeSH PubChem

Active Ingredient History

NOW

Hexylresorcinol is an organic compound with local anaesthetic, antiseptic and anthelmintic properties. It is available for use topically on small skin infections, or as an ingredient in throat lozenges. Hexylresorcinol may be used as a cosmetic biocide. Hexylresorcinol was introduced by Leonard as a urinary antiseptic with great possibilities. Used in alkaline solution it promised success in experiments in vitro. Boots Hexylresorcinol 2.4mg Throat Lozenges, marketed in UK, are used to relieve sore throat pain. Hexylresorcinol has being shown to be useful for the topical treatment of hyperpigmentation. ^NCATS

Chemistry

SMILES: CCCCCCC1=C(O)C=C(O)C=C1
InChIKey: WFJIVOKAWHGMBH-UHFFFAOYSA-N
Mol. Mass: 194.2701
ALogP: 3.22 Partition coefficient
ChEMBL Molecule:
hexylresorcinol

More Chemistry

Pharmacology

Mechanisms of Action: Missing data
Multi-specific: Missing data
Black Box: No
Availability: Missing data
Delivery Methods: Missing data
Pro Drug: No

Organizations (2)

Research & Development (2)

Organization	Org Type	FDA approvals	Clinical Trials involvement	Org ID	Force Sort

Marketing (0)

Organization	Org Type	FDA approvals	Clinical Trials involvement	Org ID	Force Sort

Indications (3)

Approved Indications (1)

Pharyngitis (approved 2006)

Experimental Indications - Clinical Trial Phases 1-4 (2)

Hyperpigmentation ()

Respiratory Tract Infections ()

Overview

Highest Phase: N/A
# of Trials: 1
# of Trial Organizations: 2

Trials by Phase

Trial	Phase	Start Date	Organizations	Indications

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue